Nasdaq:US$14.48 (+0.07) | HKEX:HK$23.70 (+0.60) | AIM:£2.29 (+0.02)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2014-06-03

ASCO 2014: A phase 1b study of VEGFR inhibitor fruquintinib in patients with pretreated advanced colorectal cancer